Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Product Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05234320
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers of the Novel Self-Administered Intranasal CG- SpikeDown Antiviral Drug

Who this might be right for
Healthy
Caregen Co. Ltd. 16
Large-scale testing (Phase 3)Study completedNCT02422797
What this trial is testing

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

Who this might be right for
HIV Infections
ViiV Healthcare 518
Testing effectiveness (Phase 2)Active Not RecruitingNCT03075696
What this trial is testing

A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 940
Testing effectiveness (Phase 2)Study completedNCT01803074
What this trial is testing

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 107
Testing effectiveness (Phase 2)Study completedNCT00377182
What this trial is testing

Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 107
Large-scale testing (Phase 3)Study completedNCT06354127
What this trial is testing

DWP450 for Treating Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Daewoong Pharmaceutical Co. LTD. 473
Large-scale testing (Phase 3)Study completedNCT00092768
What this trial is testing

MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)

Who this might be right for
Osteoarthritis
Organon and Co 500
Not applicableLooking for participantsNCT07286890
What this trial is testing

Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study

Who this might be right for
Off Pump Coronary Artery Bypass Surgery
Maquet Cardiovascular 200
Early research (Phase 1)Study completedNCT05194046
What this trial is testing

Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers

Who this might be right for
Helicobacter Pylori Associated Gastrointestinal Disease
Onconic Therapeutics Inc. 29
Early research (Phase 1)Study completedNCT01375842
What this trial is testing

Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
TumorsHematologic Malignancies
Genentech, Inc. 661
Large-scale testing (Phase 3)Study completedNCT04944290
What this trial is testing

To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Padagis LLC 447
Testing effectiveness (Phase 2)Study completedNCT04666688
What this trial is testing

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorPancreatic Cancer+3 more
PureTech 44
Early research (Phase 1)Study completedNCT04150224
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169

Who this might be right for
Healthy Subjects
Nearmedic Plus LLC 60
Not applicableStudy completedNCT02389946
What this trial is testing

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Who this might be right for
Coronary Artery DiseaseAtherosclerosis, CoronaryMyocardial Ischemia+3 more
Biotronik, Inc. 1,334
Testing effectiveness (Phase 2)Ended earlyNCT03648372
What this trial is testing

TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System

Who this might be right for
NeoplasmsLymphomaHematologic Neoplasms
Takeda 109
Large-scale testing (Phase 3)Study completedNCT01237977
What this trial is testing

Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines

Who this might be right for
Skin Aging
Medy-Tox 314
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Early research (Phase 1)Study completedNCT05238701
What this trial is testing

A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects

Who this might be right for
Huntington DiseaseTardive Dyskinesia
Luye Pharma Group Ltd. 104
Early research (Phase 1)Looking for participantsNCT07489287
What this trial is testing

GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT01161316
What this trial is testing

Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 194
Next Page